HTRA4 is a human protease implicated in various tumors, including BC, which has been associated with oncogenesis and demonstrated to promote cancer cell death and apoptosis induced by the enhanced activity of chemotherapeutic drugs in BC cell lines [43], and is a potential prognostic biomarker for BC [44]. Here, HTRA4 is linked to breast cancer.